Journal of Medical Cases, ISSN 1923-4155 print, 1923-4163 online, Open Access
Article copyright, the authors; Journal compilation copyright, J Med Cases and Elmer Press Inc
Journal website

Case Report

Volume 11, Number 12, December 2020, pages 403-406

A COVID-19 Case Complicated by Candida dubliniensis and Klebsiella pneumoniae-Carbapenem-Resistant Enterobacteriaceae


Table 1. Evolution of Labs From the Day of Admission to Discharge
Day 1Day 16Day 17Day 18Day 19Day 20Day 21Day 22Day 24Day 34
WBC: white blood count; RBC: red blood count; Hgb: hemoglobin; Hct: hematocrit; MCV: mean corpuscular volume; MCH: mean corpuscular hemoglobin; MCHC: mean corpuscular hemoglobin concentration; RDW: red cell distribution width.
WBC (k/µL)
RBC (m/µL)3.393.794.063.583.523.323.623.624.063.48
Hgb (g/dL)9.611.011.510.210.410.110.610.911.710.1
Hct (%)31.536.338.734.434.131.335.135.138.632.5
MCV (fL)92.895.895.496.29794.397.196.894.993.4
MCH (pg)28.328.328.328.429.530.429.230.128.829.0
MCHC (g/dL)30.629.829.829.730.332.
RDW (%)17.718.418.420.019.919.819.819.818.919.8
Platelet (k/µL)299413413304225203186179176145


Table 2. Sensitivity Profile of Klebsiella pneumoniae-CRE Isolated in the Patient
AntibioticMinimal inhibitory concentration (mg/L)Susceptibilities
R: resistant; I: intermediate; CRE: carbapenem-resistant Enterobacteriaceae.
Ampicillin≥ 32R
Ampicillin/sulbactam≥ 32R
Aztreonam≥ 64R
Cefazolin≥ 64R
Cefepime≥ 64R
Ceftazidime≥ 64R
Ceftriaxone≥ 64R
Gentamycin≥ 16R
Levofloxacin≥ 8R
Piperacillin/tazobactam≥ 128R
Tobramycin≥ 16R
Trimethoprim/sulfamethoxazole≥ 320R